The Vanguard Group's Stake in Avadel Pharmaceuticals

The Vanguard Group, Inc. has disclosed its opening position concerning Avadel Pharmaceuticals plc under Rule 8.3 of the Irish Takeover Panel Act, 1997. The disclosure indicates Vanguard's interests in Avadel's ordinary shares as of February 5, 2026.

Vanguard holds 5,799,501 US$0.01 ordinary shares, representing 5.95% of Avadel's relevant securities. Recent transactions by Vanguard include the purchase of 9,211 shares and the sale of 96 shares, both priced at 21.60 USD per share.

No cash-settled or stock-settled derivatives, such as options or agreements to purchase or sell, were disclosed. Furthermore, Vanguard reported no indemnity or option arrangements related to Avadel's securities, nor any agreements regarding voting rights or future acquisitions or disposals of these securities.